Maravai Lifesciences Company Top Insiders

Maravai Lifesciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.0464) % which means that it has lost $0.0464 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4432) %, meaning that it created substantial loss on money invested by shareholders. Maravai Lifesciences' management efficiency ratios could be used to measure how well Maravai Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. The Maravai Lifesciences' current Return On Tangible Assets is estimated to increase to -0.21. The Maravai Lifesciences' current Return On Capital Employed is estimated to increase to -0.24. As of now, Maravai Lifesciences' Other Assets are increasing as compared to previous years. The Maravai Lifesciences' current Total Current Assets is estimated to increase to about 497 M, while Non Currrent Assets Other are projected to decrease to under 6.9 M. The Maravai Lifesciences' current Net Income Applicable To Common Shares is estimated to increase to about 265.9 M, while Common Stock Shares Outstanding is projected to decrease to under 126.6 M.

Maravai Lifesciences Workforce Comparison

Maravai Lifesciences Profit Margins

The company has Profit Margin (PM) of (0.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.78.

Maravai Lifesciences Insider Trading History

Maravai Lifesciences Notable Stakeholders

The success or failure of an entity such as Maravai Lifesciences often depends on how effective the management is. Maravai Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Maravai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Maravai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.